Affiliation:
1. 1Department of Social and Clinical Pharmacy, Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, 500 05, Hradec Kralove, Czech Republic
Abstract
AbstractThe aim of the study was to map and analyze general practitioners` opinions of, attitudes towards and experiences with generic drugs and generic substitution (GS) in the Czech Republic. General practitioners (GPs) who took part in the annual and regional professional conferences of the Society of General Practice in the period from November 2008 until March 2009 were asked to complete the 28-item questionnaire concerning the issue of generic drugs and GS. Questions were organized in 5 sections aimed at assessing the attitude towards GS, understanding the legislation and opinions on statements related to GS. All data were analyzed using descriptive statistics and correlations were tested by selected parametric and non-parametric tests. Total of 263 completed questionnaires were returned (mean age of 52.2 years (SD=13.7), 177 (67.3%) females and 248 (94.3%) GPs having a practice specialization). 99 (37.6%) respondents have considered generic drugs to be bioequivalent to the respective brand name drugs. 121 (46.0%) respondents believed that generic drugs are of lower quality than brand name drugs. None of respondent showed acquaintance with all the legal rules for GS. Awareness of the legislation and attitude towards GS correlated with the age (p<0.001). In conclusion, distrust among GPs in generic drugs derives from poor knowledge and personal experiences.
Reference38 articles.
1. Shrank W.H., Choudhry N.K., Liberman J.N., Brennan T.A., The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money, Health Aff (Millwood)., 2011, 30, 1351–1357
2. Pechlivanoglou P., van der Veen W.J., Bos J.H., Postma M.J., Analyzing generic and branded substitution patterns in the Netherlands using prescription data, BMC Health Serv Res., 2011, 11
3. Institute of Health Information and Statistics of the Czech Republic. Economic information on health care 2010 [online]. 2011 [cited 2012-5-25]. Available from http://www.uzis.cz/en/publications/economic-information-health-care-2010
4. Aalto-Setälä V., The impact of generic substitution on price competition in Finland, Eur J Health Econ., 2008, 9, 185–191
5. Posner J., Griffin J.P., Generic substitution, Br J Clin Pharmacol., 2011, 72, 731–732
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献